Health Trials

Clinical trials

3

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

COMO: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DME

This is a phase 3 randomized, double -masked study comparing the efficacy of EYP-1901 against Aflibercept.

Participants needed: 240
Trial details
Phase: Phase 3Age: 18+Biological sex: AllType: InterventionalSponsor: EyePoint Pharmaceuticals, Inc.Updated: Jun 3, 2026Locations: 65
Eligibility criteria

Previously treated or treatment naïve patients with a documented diagnosis of ma... [+2]

BCVA using ETDRS charts <30 letters (20/250 Snellen equivalent) in the fellow ey...

Read more
Status: Recruiting

CAPRI: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DME

This is a phase 3 randomized, double -masked study comparing the efficacy of EYP-1901 against Aflibercept.

Participants needed: 240
Trial details
Phase: Phase 3Age: 18+Biological sex: AllType: InterventionalSponsor: EyePoint Pharmaceuticals, Inc.Updated: Jun 3, 2026Locations: 62
Eligibility criteria

Previously treated or treatment naïve patients with a documented diagnosis of ma... [+2]

BCVA using ETDRS charts <30 letters (20/250 Snellen equivalent) in the fellow ey...

Read more
Status: Recruiting

Evaluate the Safety of DEXYCU for the Treatment of Inflammation Following Ocular Surgery for Childhood Cataract

A Phase 3/4, Prospective, Randomized, Active Treatment-Controlled, Parallel-Design, Multicenter Study to Evaluate the Safety of DEXYCUfor the Treatment of Inflammation Following Ocular Surgery for Childhood Cataract

Participants needed: 60
Trial details
Phase: Phase 4Age: Up to 3Biological sex: AllType: InterventionalSponsor: EyePoint Pharmaceuticals, Inc.Updated: Apr 3, 2025Locations: 9
Eligibility criteria

Undergoing uncomplicated cataract surgery with or without a posterior chamber in... [+2]

Presence of clinically significant gastrointestinal, cardiovascular, hepatic, re... [+6]

Read more